InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the complete record of transactions filed by Decicco Carl, Directeur Scientifique. Officer active across 1 company, notably Foghorn Therapeutics Inc.. Aggregated, 1 filings have been recorded. Activity tracked since 9 December 2021. The latest transaction was disclosed on 9 December 2021 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
DECICCO CARL is the Chief Scientific Officer at Foghorn Therapeutics Inc. In this role, he oversees research and development initiatives, ensuring innovation and advancement of scientific projects. Carl brings expertise in the biotechnology field, contributing to the evolution of gene therapies.